Detalhe da pesquisa
1.
PML isoforms: a molecular basis for PML pleiotropic functions.
Trends Biochem Sci
; 47(7): 609-619, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35232626
2.
PML modulates epigenetic composition of chromatin to regulate expression of pro-metastatic genes in triple-negative breast cancer.
Nucleic Acids Res
; 51(20): 11024-11039, 2023 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37823593
3.
Docking Protein p130Cas Regulates Acinar to Ductal Metaplasia During Pancreatic Adenocarcinoma Development and Pancreatitis.
Gastroenterology
; 162(4): 1242-1255.e11, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34922945
4.
Conditional ablation of p130Cas/BCAR1 adaptor protein impairs epidermal homeostasis by altering cell adhesion and differentiation.
Cell Commun Signal
; 16(1): 73, 2018 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30390666
5.
Correction to: Conditional ablation of p130Cas/BCAR1 adaptor protein impairs epidermal homeostasis by altering cell adhesion and differentiation.
Cell Commun Signal
; 16(1): 90, 2018 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30477510
6.
PML restrains p53 activity and cellular senescence in clear cell renal cell carcinoma.
EMBO Mol Med
; 16(6): 1324-1351, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38730056
7.
The transcription factor HIF2α partakes in the differentiation block of acute myeloid leukemia.
EMBO Mol Med
; 15(11): e17810, 2023 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37807875
8.
Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents.
Sci Rep
; 9(1): 17729, 2019 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31758081
9.
Modeling ErbB2-p130Cas interaction to design new potential anticancer agents.
Sci Rep
; 9(1): 3089, 2019 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30816273